A new trading day began on Friday, with Zura Bio Ltd (NASDAQ: ZURA) stock price up 9.57% from the previous day of trading, before settling in for the closing price of $1.15. ZURA’s price has ranged from $0.97 to $5.07 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Meanwhile, its annual earnings per share averaged -18.57%. With a float of $38.63 million, this company’s outstanding shares have now reached $68.37 million.
Let’s look at the performance matrix of the company that is accounted for 30 employees. In terms of profitability, gross margin is 0.0%, operating margin of -3303200.0%, and the pretax margin is -3104900.0%.
Zura Bio Ltd (ZURA) Insider Updates
As we move forward, let’s examine how large-scale investors are investing in this stock of the Biotechnology Industry. The insider ownership of Zura Bio Ltd is 37.57%, while institutional ownership is 61.09%. The most recent insider transaction that took place on Nov 25 ’24, was worth 2,734,458. In this transaction Director of this company sold 1,001,633 shares at a rate of $2.73, taking the stock ownership to the 0 shares. Before that another transaction happened on Sep 11 ’24, when Company’s Director sold 3,800,000 for $2.70, making the entire transaction worth $10,260,000. This insider now owns 1,001,633 shares in total.
Zura Bio Ltd (ZURA) Performance Highlights and Predictions
According to the Wall Street analysts, stocks earnings will be around -18.57% per share during the next fiscal year.
Zura Bio Ltd (NASDAQ: ZURA) Trading Performance Indicators
Here are Zura Bio Ltd’s current performance indicators. According to the last quarter’s results, the stock had a quick ratio of 8.14.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -0.76, a number that is poised to hit -0.18 in the next quarter and is forecasted to reach -0.77 in one year’s time.
Technical Analysis of Zura Bio Ltd (ZURA)
Zura Bio Ltd (NASDAQ: ZURA) saw its 5-day average volume 0.77 million, a positive change from its year-to-date volume of 0.41 million. As of the previous 9 days, the stock’s Stochastic %D was 83.58%. Additionally, its Average True Range was 0.10.
During the past 100 days, Zura Bio Ltd’s (ZURA) raw stochastic average was set at 26.13%, which indicates a significant decrease from 87.50% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 66.03% in the past 14 days, which was lower than the 94.05% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $1.2094, while its 200-day Moving Average is $2.4592. Nevertheless, the first resistance level for the watch stands at $1.3199 in the near term. At $1.3797, the stock is likely to face the second major resistance level. The third major resistance level sits at $1.4595. If the price goes on to break the first support level at $1.1803, it is likely to go to the next support level at $1.1005. Assuming the price breaks the second support level, the third support level stands at $1.0407.
Zura Bio Ltd (NASDAQ: ZURA) Key Stats
With a market capitalization of 77.96 million, the company has a total of 68,375K Shares Outstanding. Currently, annual sales are 0 K while annual income is -45,390 K. The company’s previous quarter sales were 0 K while its latest quarter income was -17,440 K.
